The National Disease Research Interchange (NDRI) has elected Marianne Henderson, MS, CPC, ELI-MP, PMP, to its Board of Directors. Henderson is the Senior Advisor, Division Resources, of the National Cancer Institute’s Division of Cancer Epidemiology and Genetics (DCEG) at the National Institutes of Health (NIH). Elected to a three-year term as a federal liaison, Henderson brings decades of experience in biobanking and biospecimen resources to the Board.
“It is a privilege to welcome Marianne as a member of the NDRI Board of Directors,” says Bill Leinweber, President and CEO of NDRI. “Marianne is recognized internationally as a leader in the development and advancement of best practices in biobanking and biospecimen resources. Her experience and expertise will add significant value to our work at NDRI.”
Henderson joined the National Cancer Institute (NCI) in 1988 as a Biologist. She served for 20 years as Chief of DCEG’s Office of Division Operations and Analysis, before assuming her current role as the Senior Advisor for Division Resources for DCEG. She also served as Senior Advisor on Biobanking for the NCI Center for Global Health. Henderson has extensive experience in laboratory and biorepository management, government contracts, operations, international scientific collaboration, and infrastructure planning for largescale molecular epidemiology studies for the Division.
Henderson is a founding member of the NCI Biospecimen Coordinating Committee and participated in the development and revision of the first and second editions of NCI’s Best Practices for Biospecimen Resources. She is a past president of the International Society for Biological and Environmental Repositories (ISBER) and received that organization’s Pioneer’s Award and Distinguished Leadership and Service Award. She participated in the development of the ISBER Best Practices, 5th edition, especially focused on the expansion of the information management section. She is also a member of numerous national and international scientific advisory committees and working groups.
“I am honored to join the Board of NDRI and share my experience,” said Henderson. “NDRI is a leader in the facilitation of human tissue for research, and they are continually innovating to improve service for investigators. I am especially excited to share my expertise with their CAP-accredited biorepository team.”
Dr. Mary J.C. Hendrix, Ph.D., Chair of the NDRI Board and President of Shepherd University, shared, “We are thrilled to welcome Marianne to the NDRI Board of Directors. Her deep understanding of biorepositories and technology transfer, as well as her exemplary tenure with NCI, will truly benefit both our NDRI team and our international network of researchers.”